In Vitro Biocompatibility and Release Characteristics of Polypyrrole-bupivacaine Coatings for Neurostimulators

Lead Research Organisation: University of East Anglia
Department Name: Chemistry

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications


10 25 50
 
Description New electropolmeric systems developed which can incorporate deliverable drugs. Emphasis of Follow-on-Fund grant shifted to new coatings for stents and, in conjuction with certain biomedical companies, neural stimulators.
Exploitation Route Patents and Know how arising in part from this study were purchased by US biomedical company in 2011.
Sectors Pharmaceuticals and Medical Biotechnology
 
Description Patents and know how arising in part from Follow on Fund work purchased by US biomed company.
First Year Of Impact 2012
Sector Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Economic
 
Description Chameleon Biosurfaces Ltd 
Organisation Biotectix
Country United States of America 
Sector Private 
PI Contribution Synthesis and electropolymerisation of monomers
Collaborator Contribution Characterisation of biophysical properties.
Impact Patents.
Start Year 2006
 
Title Coating on titanium nitride 
Description This patent application covers applications of electropolymers for heart stimulation applications. 
IP Reference UK patent application 1012808.0 (Submitted: 2010) US patent: Implantable Electrode US 2012/0029585 (publication date: 2012) 
Protection Patent granted
Year Protection Granted 2010
Licensed Commercial In Confidence
Impact Patent transferred to US biomedical company. Impact unknown.
 
Title Polymer coatings on medical devices 
Description This patent describes low thrombogenicity electropolymer materials including their preparation and biophysical characterisation. 
IP Reference EP2155275(A2) 
Protection Patent granted
Year Protection Granted 2010
Licensed Commercial In Confidence
Impact Patent transferred to US biomedical company. Commercial developments unknown.